[go: up one dir, main page]

WO2001001150A3 - Diagnostic test for thrombotic or thromboembolic disease - Google Patents

Diagnostic test for thrombotic or thromboembolic disease Download PDF

Info

Publication number
WO2001001150A3
WO2001001150A3 PCT/US2000/017977 US0017977W WO0101150A3 WO 2001001150 A3 WO2001001150 A3 WO 2001001150A3 US 0017977 W US0017977 W US 0017977W WO 0101150 A3 WO0101150 A3 WO 0101150A3
Authority
WO
WIPO (PCT)
Prior art keywords
thrombotic
diagnostic test
thromboembolic disease
thromboembolic
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/017977
Other languages
French (fr)
Other versions
WO2001001150A9 (en
WO2001001150A2 (en
Inventor
Timothy A Morris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Priority to EP00946908A priority Critical patent/EP1192183A2/en
Priority to AU60593/00A priority patent/AU781249B2/en
Priority to JP2001507103A priority patent/JP2003503425A/en
Priority to CA002372700A priority patent/CA2372700A1/en
Publication of WO2001001150A2 publication Critical patent/WO2001001150A2/en
Anticipated expiration legal-status Critical
Publication of WO2001001150A3 publication Critical patent/WO2001001150A3/en
Publication of WO2001001150A9 publication Critical patent/WO2001001150A9/en
Priority to AU2005203615A priority patent/AU2005203615A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Thrombotic or thromboembolic disease is detected or monitored by determining the presence or amount of FPB in a physiological sample.
PCT/US2000/017977 1999-06-30 2000-06-30 Diagnostic test for thrombotic or thromboembolic disease Ceased WO2001001150A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP00946908A EP1192183A2 (en) 1999-06-30 2000-06-30 Diagnostic test for thrombotic or thromboembolic disease
AU60593/00A AU781249B2 (en) 1999-06-30 2000-06-30 Diagnostic test for thrombotic or thromboembolic disease
JP2001507103A JP2003503425A (en) 1999-06-30 2000-06-30 Diagnostic tests for thrombotic or thromboembolic disorders
CA002372700A CA2372700A1 (en) 1999-06-30 2000-06-30 Diagnostic test for thrombotic or thromboembolic disease
AU2005203615A AU2005203615A1 (en) 1999-06-30 2005-08-12 Diagnostic test for thrombotic or thromboembolic disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14173499P 1999-06-30 1999-06-30
US60/141,734 1999-06-30

Publications (3)

Publication Number Publication Date
WO2001001150A2 WO2001001150A2 (en) 2001-01-04
WO2001001150A3 true WO2001001150A3 (en) 2002-02-07
WO2001001150A9 WO2001001150A9 (en) 2002-07-25

Family

ID=22496986

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/017977 Ceased WO2001001150A2 (en) 1999-06-30 2000-06-30 Diagnostic test for thrombotic or thromboembolic disease

Country Status (5)

Country Link
EP (1) EP1192183A2 (en)
JP (1) JP2003503425A (en)
AU (1) AU781249B2 (en)
CA (1) CA2372700A1 (en)
WO (1) WO2001001150A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE349703T1 (en) * 2002-08-09 2007-01-15 Dade Behring Marburg Gmbh COMBINATION OF CRP AND D-DIMER FOR DIAGNOSING DEEP VEIN THROMBOSIS
EP2909626B1 (en) * 2012-10-18 2018-07-04 metanomics GmbH Means and methods for determining a clearance normalized amount of a metabolite disease biomarker in a sample
CA2979812C (en) * 2015-03-20 2023-08-29 Universite Paris Descartes Isolated peptides and fragments thereof from fibrinogen for use as drugs, particularly in skin inflammatory diseases
CN114550855A (en) * 2020-11-25 2022-05-27 上海森亿医疗科技有限公司 Venous thromboembolism prediction method, device, terminal and medium based on artificial intelligence

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807538A (en) * 1992-03-13 1998-09-15 Diatide, Inc. Technetium-99m labeled peptides for imaging inflammation
WO1999005176A1 (en) * 1997-07-25 1999-02-04 The New York Blood Center, Inc. Monospecific antibody reactive with fibrinogen and fibrinopeptide b

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807538A (en) * 1992-03-13 1998-09-15 Diatide, Inc. Technetium-99m labeled peptides for imaging inflammation
WO1999005176A1 (en) * 1997-07-25 1999-02-04 The New York Blood Center, Inc. Monospecific antibody reactive with fibrinogen and fibrinopeptide b

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
BILEZIKIAN S B ET AL: "RADIOIMMUNOASSAY OF HUMAN FIBRINOPEPTIDE BETA AND KINETICS OF FIBRINOPEPTIDE CLEAVAGE BY DIFFERENT ENZYMES", JOURNAL OF CLINICAL INVESTIGATION,US,NEW YORK, NY, vol. 56, no. 2, August 1975 (1975-08-01), pages 438 - 445, XP002914824, ISSN: 0021-9738 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1991, NAIM J O ET AL: "THE GENERATION OF ANTIBODY IN MICE TO TUFTSIN A NATURALLY OCCURRING PHAGOCYTOSIS STIMULATING TETRAPEPTIDE", XP002154954, Database accession no. PREV199192088050 *
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; KAIZU K ET AL.: "ROLE OF INTRARENAL COAGULATION AND ANTICOAGULANT THERAPY IN THE PROGRESSION OF DIABETIC NEPHROPATHY", XP002154952, retrieved from STN *
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; SHIBATA K ET AL.: "INTRAGLOMERULAR COAGULATION AND FIBRINOLYSIS IN HUMAN PRIMARY GLOMERULAR DISEASES", XP002154953, retrieved from STN *
IMMUNOLOGICAL INVESTIGATIONS, vol. 20, no. 4, 1991, pages 351 - 364, ISSN: 0882-0139 *
K Y HUI ET AL: "Monoclonal Antibodies to a Synthetic Fibrin-Like Peptide Bind to Human Fibrin but Not Fibrinogen", SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, vol. 222, 1 September 1983 (1983-09-01), pages 1129 - 1132, XP002080953, ISSN: 0036-8075 *
NIPPON JINZO GAKKAI SHI JAPANESE JOURNAL OF NEPHROLOGY (1991 AUG) 33 (8) 719-29 *
NIPPON JINZO GAKKAI SHI JAPANESE JOURNAL OF NEPHROLOGY (1993 JAN) 35 (1) 35-42 *
OWENS R J ET AL: "THE GENETIC ENGINEERING OF MONOCLONAL ANTIBODIES", JOURNAL OF IMMUNOLOGICAL METHODS,NL,ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, vol. 168, 1994, pages 149 - 165, XP002914829, ISSN: 0022-1759 *
WILNER G D ET AL: "IMMUNOCHEMICAL ANALYSIS OF RABBIT ANTIHUMAN FIBRINOPEPTIDE B ANTIBODIES", BIOCHEMISTRY,US,AMERICAN CHEMICAL SOCIETY. EASTON, PA, vol. 18, no. 23, 1979, pages 5078 - 5082, XP002914823, ISSN: 0006-2960 *

Also Published As

Publication number Publication date
AU6059300A (en) 2001-01-31
WO2001001150A9 (en) 2002-07-25
JP2003503425A (en) 2003-01-28
CA2372700A1 (en) 2001-01-04
EP1192183A2 (en) 2002-04-03
AU781249B2 (en) 2005-05-12
WO2001001150A2 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
WO2001042502A3 (en) Methods for disease detection
AU2001283066A1 (en) Hygiene monitoring
AU2002327308A1 (en) Methods for evaluating pathologic conditions using extracellular rna
WO2001006248A3 (en) Biosensors for monitoring air conditioning and refrigeration processes
AU1802899A (en) Blood analyte monitoring through subcutaneous measurement
HK1052218A1 (en) Compositions containing a urea derivative dye for detecting an analyte
CA2230372A1 (en) Quantitation of p97 to diagnose and monitor alzheimer's disease
AU3433601A (en) Multiple analyte assay device with sample integrity monitoring system
WO2002046766A3 (en) Bioanalytical reagent, method for production thereof, sensor platforms and detection methods based on use of said bioanalytical reagent
WO2005003732A3 (en) Diagnostic test for analytes in a sample
WO2002055008A3 (en) Meter strip dispenser assembly
EP2251433A3 (en) Multichemistry measuring device and test strips
AU3465399A (en) Diagnostic modified-nucleoside detection assay
SE9604815D0 (en) A method or diagnosis
WO2001001150A3 (en) Diagnostic test for thrombotic or thromboembolic disease
ES2164822T3 (en) BIOSENSORS SENSITIVE TO THE MASS.
AU6415000A (en) Indicator peptide for diagnosing and/or predicting cardiovascular and/or endothelial diseases, antibody composition and immunoassay
CA2407760A1 (en) Methods for diagnosis of low grade astrocytoma
AU2001259476A1 (en) Assay for detecting, measuring and monitoring the activities and concentrations of proteins and methods of use thereof
WO2001096864A3 (en) A method for detecting a lipoprotein-acute phase protein complex
AU5907998A (en) Measuring analytes with metal-ligand complex probes
WO2000039581A3 (en) Test system for detecting different markers, and production and use thereof
FR2813639B1 (en) METHOD FOR DIAGNOSING A SENSOR, IN PARTICULAR A SENSOR OF CLICKS
WO2004099784A3 (en) Method for determining a tissue degradation process by detection of fibromodulin neoepitopes
WO2003054547A3 (en) Diagnosis of dementia utilizing thrombospondin

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CU CZ DE DK DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 60593/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000946908

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2372700

Country of ref document: CA

Ref country code: CA

Ref document number: 2372700

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CU CZ DE DK DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWP Wipo information: published in national office

Ref document number: 2000946908

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CU CZ DE DK DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/4-4/4, DRAWINGS, REPLACED BY NEW PAGES 1/4-4/4; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE